Everest Medicines Announces Approval of “B” Marker Removal from Company’s Stock Code by the Hong Kong Stock Exchange
SHANGHAI, April 22, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that The Stock Exchange of Hong Kong Limited (the "Stock Exchange") has approved the Company's application to remove the "B" marker from its stock short name, as the company...
The Role of Treg Epitopes (Tregitopes) in Antibody Maturation Uncovered in New EpiVax Study: Implications for Therapeutic Antibodies
PROVIDENCE, R.I., April 21, 2025 /PRNewswire/ -- EpiVax, Inc. announces a new study published in Frontiers in Immunology unveiling the impact of peptides known as "Tregitopes" on antibody maturation during immune response. Lymph nodes contain antibodies that undergo changes to their sequence as they adapt to their immune target, such as a flu...
BGM Group Acquires Wonder Dragon to Accelerate “Healthcare” Strategy
CHENGDU, China, April 21, 2025 /PRNewswire/ -- BGM Group Ltd. (Nasdaq: BGM) today announced that it has signed a definitive transaction agreement with the existing shareholders of Wonder Dragon Global Limited ("Wonder Dragon"), to acquire 100% of the equity interests of Wonder Dragon by issuing 38,165,290 Class A ordinary shares at a price of $2 per share, for a...
Kelun-Biotech’s novel ADC drug SKB518 has been granted the clearance of IND from the United States Food and Drug Administration (FDA)
CHENGDU, China, April 21, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company has been granted the clearance of investigational new drug (IND) application to initiated the clinical study of its potential first-in-class innovative ADC drug SKB518 from the United States Food and Drug Administration (FDA). In June...
UK Clinical Study Finds Sky Labs’ Smart Ring ‘CART-I’ More Sensitive Than Apple Watch for AFib Detection
Published in the international journal Heart Rhythm O2, the clinical study demonstrates that CART-I achieved 84.6% sensitivity – higher than Apple Watch's 69.1% Sky Labs also recognized with Korea's top tech honor: IR52 Jang Young-sil Award – Prime Minister's Award SEOUL, South Korea, April 21, 2025 /PRNewswire/ -- Sky Labs, a health-tech startup based in South Korea, announced...
INTCO Medical Launches New Syntex™ Synthetic Disposable Latex Gloves Featuring Breakthrough Performance Beyond Natural Latex
ZIBO, China, April 21, 2025 /PRNewswire/ -- INTCO Medical ("INTCO" or "the Company"), the world's leading manufacturer of disposable gloves, has announced the global launch of its exclusive patented Syntex™ Synthetic Disposable Latex Gloves product. Breaking natural latex boundaries, Syntex™ redefines glove quality, safety, and performance.  Syntex™ Synthetic Latex (Exam) Gloves Outperforms Latex, Outperforms Costs Syntex™ gloves have...
Acepodia Presents Preclinical Data on Antibody-Dual-Drugs Conjugation (AD2C) technology at AACR Annual Meeting 2025
ALAMEDA, Calif. and TAIPEI, April 21, 2025 /PRNewswire/ -- Acepodia (6976: TT) today announced the presentation of new preclinical data highlighting its proprietary dual-payload antibody-drug conjugate (AD2C) for hepatocellular carcinoma (HCC). The data will be featured at the American Association for Cancer Research (AACR) Annual Meeting 2025, which will take place from April 25 to April 30, 2025...
Rona Therapeutics Announces NMPA Approval of IND Application for RN1871, a Novel Angiotensinogen (AGT)-Targeting siRNA Drug for Hypertension
SHANGHAI, April 21, 2025 /PRNewswire/ -- Rona Therapeutics, a biotechnology company pioneering innovative RNA-targeted therapies, announced that the Investigational New Drug (IND) application for RN1871, a small interfering RNA (siRNA) drug targeting angiotensinogen (AGT), has been approved by China's National Medical Products Administration (NMPA). RN1871 is designed to silence AGT mRNA expression in the liver, precisely inhibiting the production of the...
Connecting Care With Clicks Announces Partnership with Prince Court Medical Center and 8 CPD Points for HCPs
KUALA LUMPUR, Malaysia, April 21, 2025 /PRNewswire/ -- Ahead of Connecting Care With Clicks 2025, Medical Channel Asia (MCA) has unveiled an expanded speaker lineup and announced Prince Court Medical Centre as the event's official Healthcare Professional (HCP) Engagement Partner Hospital. Taking place on 21 June 2025 at InterContinental Kuala Lumpur, this one-day conference is shaping up to be the...
DAAN Biotherapeutics and GC Cell Sign Exclusive Technology Transfer Agreement for Tumor Antigen-Specific Antibody Sequence to Advance CAR-T and CAR-NK Cell Therapies
SEOUL, South Korea, April 21, 2025 /PRNewswire/ -- DAAN Biotherapeutics, a leading innovative drug development company specializing in T-Cell receptor (TCR)-based therapies, has signed an exclusive licensing agreement with GC Cell, a gene and cell therapy firm, for the tumor antigen-specific antibody sequence. The agreement grants GC Cell exclusive rights to utilize DAAN...
